-
Mashup Score: 14Healthcare Unfiltered: ABIM and MOC: The Epic Debate With Richard Baron and Aaron Goodman on Apple Podcasts - 9 month(s) ago
Show Healthcare Unfiltered, Ep ABIM and MOC: The Epic Debate With Richard Baron and Aaron Goodman – Aug 8, 2023
Source: podcasts.apple.comCategories: Latest Headlines, Partners & KOLsTweet-
RT @chadinabhan: @abgutman The full episode is here https://t.co/74FPoMUhAT
-
RT @chadinabhan: @abgutman The full episode is here https://t.co/74FPoMUhAT
-
-
Mashup Score: 6FDA approves olaparib with abiraterone and prednisone - 11 month(s) ago
FDA approves olaparib with abiraterone and prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer
Categories: Latest Headlines, UrologyTweet-
And it’s finally out: FDA just approves olaparib+abiraterone for mCRPC pra with BRCA mut. #propel f/ ODAC recs. More news with #talapro2 #magnitude soon @FDAOncology ? @neerajaiims @AarmstrongDuke @DrChoueiri @GUONCGarciaJA @AarmstrongDuke @DrRanaMcKay https://t.co/0cmIbKj5ud
-
-
Mashup Score: 0Prior Authorization - 12 month(s) ago
Ask your lawmakers to protect patients’ timely access to care by streamlining prior authorization requirements in the Medicare Advantage program
Source: asco.quorum.usCategories: Latest Headlines, UrologyTweet-
I contacted my lawmakers about protecting patients' timely access to care. Join me! #ASCOAdvocacy https://t.co/TBTfDDS5yt
-
-
Mashup Score: 3NewsDetails - 1 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 2676226624 Four Early-Career Cancer Researchers Earn Prestigious Annual Award from NCCN Foundation National Comprehensive Cancer Network’s…
Source: NCCNCategories: Latest Headlines, UrologyTweet-
RT @NCCN: Four early-career cancer researchers earn prestigious annual award from NCCN Foundation. Learn more: https://t.co/UGZfk8kYtw #NCC…
-
-
Mashup Score: 2Program Guide – ASCO Meeting Program Guide - 1 year(s) ago
AuthorsRay Manneh KoppSociedad de Oncología y Hematología del Cesar, Valledupar, ColombiaRay Manneh Kopp, Carmen Alaez Verson, Martin Angel, Arturo Delgado, Pedro H Isaacsson Velho, Alejandro Manduley, Melissa Barbieri, Carmen Vargas, Francisco Gonzalez, Pedro C. BarataOrganizationsSociedad de Oncología y Hematología del Cesar, Valledupar, Colombia, Instituto Nacional de Medicina Genómica, Ciudad…
Source: meetings.asco.orgCategories: Latest Headlines, UrologyTweet-
RT @Martin_AngelMD: Prevalence of gHRR mutations in #ProstateCancer in a LATAM population. @raymanneh @PBarataMD https://t.co/AJX5HWbsSv…
-
-
Mashup Score: 0Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 2 year(s) ago
Our mission is to help patients with cancer live longer with better quality lives
Source: Telix PharmaceuticalsCategories: Latest Headlines, UrologyTweet-
Hot of the press: Zircon phase III trial meets primary endpoint! Great news for our RCC patients - @neerajaiims @montypal @DrChoueiri @IKCCorg @kcCURE @TelixPharma https://t.co/mdnezNlF07
-
-
Mashup Score: 0Prostate Cancer Patient Summits - 2 year(s) ago
New Orleans Summit: Join the Prostate Cancer Foundation and The Departments of Tulane Urology, Medical Oncology, and Radiation Oncology for a Prostate
Source: Prostate Cancer FoundationCategories: Latest Headlines, UrologyTweet-
Join PCF and Depts of Tulane Urology, Medical Oncology, and Radiation Oncology for a Prostate Cancer Patient Summit in New Orleans. Leading experts will discuss everything you want to know about prostate cancer. Register by Sept 16 - https://t.co/lVlLGckP7X @PCFnews https://t.co/DELwc9Twtx
-
-
Mashup Score: 2Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer Patients - 2 year(s) ago
: Multiple studies have confirmed a high prevalence of prognostic germline mutations in prostate cancer. In recognition, the NCCN guidelines and recom…
Source: www.sciencedirect.comCategories: Latest Headlines, UrologyTweet-
RT @arnabguonc: Rising star @Yash_Suri writes on the Uptake and Challenges of Genetic Testing Guidelines ... https://t.co/oTqT9C5mF3 Sign…
-
-
Mashup Score: 0
I participated in “Modern Treatment Approaches to Prostate Cancer,” a CME/MOC activity from @PeerView
Source: api.learn2.peerview.comCategories: Latest Headlines, UrologyTweet-
RT @SpeakJen: See a new #prostatecancer activity via @PeerView @PBarataMD #SUO21 #ProstateCancer #CME #MOC https://t.co/jl3RrUbcet
-
-
Mashup Score: 44427Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 - 3 year(s) ago
Using the Drug ivermectin to treat COVID-19 can be dangerous and even lethal. The FDA has not approved the drug for that purpose.
Categories: Latest Headlines, UrologyTweet-
RT @US_FDA: You are not a horse. You are not a cow. Seriously, y'all. Stop it. https://t.co/TWb75xYEY4
-
I’m thankful to everyone who has messaged me about today’s podcast - this podcast is on its way to be the most listened to podcast since I started 4 years ago. Clearly, TOP of MIND topic to all docs and stakeholders. @AaronGoodman33 MOC & ABIM. https://t.co/74FPoMUhAT